eClinical Tech News

Quanta Therapeutics will present data on QTX3544, an oral, G12V-preferring, multi-KRAS inhibitor, at the 2025 AACR Annual Meeting. QTX3544...

Bolt Biotherapeutics will present Phase 1 clinical trial data for BDC-3042, a dectin-2 agonist antibody targeting tumor-associated macrophages (TAMs),...

Polyrizon Ltd. has initiated preclinical studies for intranasal delivery of benzodiazepines (BZDs) using its proprietary Trap and Target™ platform....

Corvus Pharmaceuticals provided a business update and announced its financial results for the fourth quarter and year ending December...

NeuroNOS, a Beyond Air subsidiary, secured $2 million in private equity funding to advance the preclinical development of a...

Biomea Fusion announced preclinical and clinical data for its investigational menin inhibitor, icovamenib, at the ATTD 2025 Conference. The...

Tenaya Therapeutics announced positive preclinical data for TN-201, its gene therapy candidate for MYBPC3-associated hypertrophic cardiomyopathy (HCM), published in...

Bionano Genomics and Greenwood Genetic Center (GGC) published a study in •Genome Research• demonstrating the use of optical genome...

Tonix Pharmaceuticals announced that the FDA will not require an advisory committee meeting for their New Drug Application (NDA)...